Grants and Contributions

About this information

In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.

The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.

Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.

Found eight records

$357,087.00

Nov 17, 2025

For-profit organization

Agreement:

MNC Collab - GREEN-MNP-BUFFER: Development of Functionalized Green MNPs and Buffers for Purification and Diagnostics

Agreement Number:

1039317

Duration: from Nov 17, 2025 to Aug 21, 2026
Description:

As part of the international consortium project “GREEN-MNP-BUFFER," this project will focus on developing next-generation magnetic nanoparticle and buffer formulations using proprietary, sustainable, and biodegradable chemistries.

Organization: National Research Council Canada
Program Name: Industrial Research Assistance Program
Location: Montreal, Quebec, CA H3N 1Y4

$71,500.00

Dec 2, 2024

For-profit organization

Agreement:

MNC Collab - MNP-OLIGO - Development of Functionalized MNPs and Oligonucleotides for Purification and Diagnostics

Agreement Number:

1025518

Duration: from Dec 2, 2024 to Mar 31, 2025
Description:

As part of Multinational Corporate Collaboration Program, the project “Development of Functionalized MNPs and Oligonucleotides for Purification and Diagnostics” will focus on advancing technologies for improved diagnostics and higher yields and purity of oligos/nucleic acids

Organization: National Research Council Canada
Program Name: Industrial Research Assistance Program – Contributions to Firms
Location: Montreal, Quebec, CA H3N 1Y4

$30,000.00

Oct 28, 2024

For-profit organization

Agreement:

Youth: Laboratory Chemical Technician

Agreement Number:

1023902

Duration: from Oct 28, 2024 to Jun 6, 2025
Description:

The youth will join the firm's’ oligonucleotide synthesis team to support the development, evaluation, production, and delivery of chemically-modified aptamer sequences and other oligonucleotide therapeutic candidates for the firm's clients.

Organization: National Research Council Canada
Program Name: Industrial Research Assistance Program – Youth Employment Program
Location: Montreal, Quebec, CA H3N 1Y4

$63,000.00

Sep 16, 2024

For-profit organization

Agreement:

ARP - A novel diagnostic test for Haplosporidium nelsoni (MSX) in shellfish

Agreement Number:

1022902

Duration: from Sep 16, 2024 to Dec 1, 2024
Description:

The firm is advancing the development of rapid diagnostic workflows for detecting Haplosporidium nelsoni in oysters, leveraging its expertise in sample preparation using magnetic nanoparticles and specialized buffer formulations. The project focuses on the efficient extraction of genomic material, the design of sensitive PCR and isothermal detection systems, and the production of high-purity oligonucleotide probes and primers. With ISO 9001-certified manufacturing capabilities, the firm is well-positioned to commercialize these diagnostic tools, enhancing pathogen detection and supporting the oyster industry.

Organization: National Research Council Canada
Program Name: Industrial Research Assistance Program – Contributions to Firms
Location: Montreal, Quebec, CA H3N 1Y4

$527,000.00

Jul 10, 2023

For-profit organization

Agreement:

Novel DNA-Encoded Library Platform for Next-Generation Aptamers Drug Discovery

Agreement Number:

1008172

Duration: from Jul 10, 2023 to Mar 15, 2025
Description:

The Firm seeks to advance the state of the art in aptamer drug development through the development of novel chemistries of non-natural or modified natural nucleotides and synthesis and purification methods for a large DNA-encoded aptamer library. The technology will leverage core expertise in the design and manufacturing of magnetic nanoparticles and in-house large-scale high-purity synthesis of oligonucleotide services to provide the biopharmaceutical and biotechnology industry with products and services that will accelerate the design and screening of aptamers for therapeutic drug discovery.

Organization: National Research Council Canada
Program Name: Industrial Research Assistance Program – Contributions to Firms
Location: Montreal, Quebec, CA H3N 1Y4

$940,000.00

Jan 27, 2022

For-profit organization

Agreement:

2122-HQ-000119

Agreement Number:

2122-HQ-000119

Duration: from Jan 27, 2022 to Feb 1, 2024
Description:

Not a Project (Mandated or Core Funding)

Organization: Health Canada
Program Name: Canadian Health Systems and Programs
Location: Montreal, Quebec, CA H3E 1M3

$266,500.00

Aug 24, 2020

For-profit organization

Agreement:

Magnetic-Based Reagents for Viral RNA Extraction in Clinical and Point-of-Care Applications

Agreement Number:

955723

Duration: from Aug 24, 2020 to Nov 23, 2020
Description:

COVID-19 Challenge: To develop a proof of concept for The National Research Council Canada (NRC) is seeking a solution for reagents required for nucleic acid sample preparation and rapid and efficient SARS-CoV-2 Ribonucleic Acid (RNA) extraction in order to perform downstream molecular diagnostics of COVID-19 with capability to integrate within existing and/or potential microfluidic platforms for sample-to-answer solutions that can be deployed on the frontline for rapid testing.

Organization: National Research Council Canada
Program Name: Innovative Solutions Canada
Location: Montreal, Quebec, CA H3N 1Y4

$142,000.00

Mar 6, 2020

For-profit organization

Agreement:

1920-HQ-000287

Agreement Number:

1920-HQ-000287

Duration: from Mar 6, 2020 to Mar 31, 2020
Description:

Not a Project (Mandated or Core Funding)

Organization: Health Canada
Program Name: Canadian Health Systems and Programs
Location: Montreal, Quebec, CA H3E 1M3